Literature DB >> 1169134

Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients.

A G Morrow, B A Reitz, S E Epstein, W L Henry, D M Conkle, S B Itscoitz, D R Redwood.   

Abstract

The results of operative treatment in 83 patients with idiopathic hypertrophic subaortic stenosis (IHSS) are described. Most patients with the disease are asymptomatic, or derive satisfactory symptomatic improvement from nonoperative therapy: administration of propranolol, exerice limitation, control of arrhythmia, etc. Operation is required, however, in 10-15% of patients, those who remain severely symptomatic after nonoperative treatment or who become refractory to it. Operation relieves symptoms in IHSS by relieving obstruction to left ventricular outflow, and for a patient to be considered an operative candidate severe obstruction must be documented at left heart catheterization either under resting conditions or after provocative interventions. All 83 patients were severely incapacitated--58 in Class III and 24 in Class IV. Seventy had obstruction at rest (average gradient 96 mm Hg), and 13 had only provocable obstruction. At operation the hypertrophic interventricular septum was exposed via an aortotomy, and a vertical bar of muscle was resected between parallel myotomy incisions. There were six operative deaths (7%); no patient has died since 1970. Seven patients have died late after operation, five of them from causes unrelated to their heart disease or the operation. All surviving patients describe symptomatic improvement. Fifty-two patients with obstruction at rest preoperatively (average gradient 95 mm Hg) have been studied postoperatively: no resting gradient was evident in 47, while in the remaining five the gradient was less than 25 mm Hg. Recurrence of obstruction has never been observed at late catheterization (21 pts) or late echocardiographic examination (37 pts). Obstruction could not be provoked postoperatively in ten of the 11 patients who had large gradients only with the Valsalva maneuver or isoproterenol administration preoperatively. Obstructed and provocable obstructed patients had similar symptomatic improvement after operation. A variety of rhythm and conduction abnormalities were observed both pre and postoperatively, and these are described in detail. The results of operation in these 83 patients with IHSS demonstrate that gratifying symptomatic and hemodynamic improvement uniformly follows left ventriculomyotomy and myectomy. Relief of obstruction and amelioration of symptoms have proved to be long-lasting during postoperative observation periods extending to 14 years. Continued application of the operative procedure in properly selected patients appears to be indicated.

Entities:  

Mesh:

Year:  1975        PMID: 1169134     DOI: 10.1161/01.cir.52.1.88

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  49 in total

Review 1.  Analysis of dual-chamber pacing as a treatment for refractory limiting symptoms in patients with obstructive hypertrophic cardiomyopathy.

Authors:  B J Maron
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

2.  Mitral annular reconstruction with anterior leaflet flip-over in concomitant surgery for mitral regurgitation associated with extensive posterior annular calcification and hypertrophic obstructive cardiomyopathy.

Authors:  Hiroshi Okamoto; Akinori Tamenishi; Yutaka Itoh; Takao Niimi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-02

3.  Coronary flow reserve in hypertrophic cardiomyopathy: relation with microvascular dysfunction and pathophysiological characteristics.

Authors:  M J Kofflard; M Michels; R Krams; M Kliffen; M L Geleijnse; F J Ten Cate; P W Serruys
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

4.  Hypertrophic cardiomyopathy in identical twins.

Authors:  J M Reid; A B Houston; E Lundmark
Journal:  Br Heart J       Date:  1989-11

Review 5.  Management of the mitral valve in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Joon Hwa Hong; Anita Nguyen; Hartzell Vernon Schaff
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-05-07

6.  Minimally Invasive Versus Full-Sternotomy Septal Myectomy for Hypertrophic Cardiomyopathy.

Authors:  Farah N Musharbash; Matthew R Schill; Vivek H Hansalia; Richard B Schuessler; Jeremy E Leidenfrost; Spencer J Melby; Ralph J Damiano
Journal:  Innovations (Phila)       Date:  2018 Jul/Aug

7.  Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.

Authors:  Amelie Burghardt; Frank van Buuren; Zisis Dimitriadis; Tim Grübbel; Hubert Seggewiss; Smita Scholtz; Dieter Horstkotte; Lothar Faber
Journal:  Clin Res Cardiol       Date:  2018-02-16       Impact factor: 5.460

Review 8.  From genotype to phenotype: a longitudinal study of a patient with hypertrophic cardiomyopathy due to a mutation in the MYBPC3 gene.

Authors:  Adam Jacques; Anita C Hoskins; Jonathan C Kentish; Steven B Marston
Journal:  J Muscle Res Cell Motil       Date:  2009-02-14       Impact factor: 2.698

9.  Visualization of transcoronary ablation of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: a comparison between cardiac MRI, invasive measurements and echocardiography.

Authors:  Christian Sohns; Samuel Sossalla; Jan D Schmitto; Claudius Jacobshagen; Björn W Raab; Silvia Obenauer; Lars S Maier
Journal:  Clin Res Cardiol       Date:  2010-02-21       Impact factor: 5.460

10.  Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients.

Authors:  F H Gietzen; C J Leuner; L Obergassel; C Strunk-Mueller; H Kuhn
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.